NCT02623946 Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients Status COMPLETED Phase N/A
NCT02618902 A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial Status COMPLETED Phase PHASE1
NCT02607020 Self-Management Program Based on Physical Exercises in People With Multiple Sclerosis Status UNKNOWN Phase NA
NCT02606630 [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis Status TERMINATED Phase PHASE1
NCT02606604 Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS Status COMPLETED Phase NA
NCT02601885 A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT02592265 Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden Status COMPLETED Phase N/A
NCT02588053 Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)? Status COMPLETED Phase N/A
NCT02587195 A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period Status COMPLETED Phase PHASE3
NCT02583386 Comprehensive Fall Prevention and Detection in Multiple Sclerosis Status COMPLETED Phase NA
NCT02580435 Deciphering the Role of the Gut Microbiota in Multiple Sclerosis Status UNKNOWN Phase N/A
NCT02576717 A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT02571335 Impacts of Different Training Modes (Intense Versus Ordinary) on the Immune System and Memory Functions in pwMS Status COMPLETED Phase NA
NCT02553525 Effects of Stimulation Patterns of Deep Brain Stimulation Status ENROLLING_BY_INVITATION Phase NA